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Objectives: Except for compression therapy, physical therapy has scarcely been evaluated in the treatment of chronic
venous disorders (CVD). Spa treatment is a popular way to administer physical therapy for CVD in France, but its efficacy
has not been evaluated yet. This study aimed to assess the efficacy of balneotherapy associated with patient education, as
performed in the spa resort of La Léchère, in patients with advanced chronic venous insufficiency (CEAP clinical classes
C4/C5).
Methods: The study was a randomized controlled trial, spa therapy being administered on top of the usual medical care.
Evaluation was by a blinded independent investigator. Subjects were patients with primary or post-thrombotic CVDwith
skin changes but no active ulcer (C4a, C4b, or C5), living in Grenoble area, and willing to undergo a spa treatment course
in La Léchère. The treated group had the three week spa treatment course in La Léchère, soon after randomization; the
control group also had a spa treatment, but starting at day 365. The treatment consisted of four balneology sessions per
day, six days a week during three weeks, and three educational workshops. An independent follow-up was performed in
Grenoble hospital every three months for 15 months. The main outcome criterion was the severity of the skin changes,
as evaluated by means of malleolar chromametry. Quality of life, as measured by the Chronic Venous Insufficiency
Questionnaire 2 scale, a visual analog scale (VAS) for leg symptoms, and the occurrence of leg ulcers were used as
secondary criteria. The year after spa treatment in the treated group was compared with the year before spa treatment in
the control group.
Results: Fifty-nine subjects were enrolled (29 in the treatment group and 30 in the control group). No statistically
significant difference between groups was found at study onset regarding age, sex, etiology, CEAP “C” class, and the
outcome variables. After treatment, chromametry showed significantly decreased pigmentation and erythema in the
treatment group compared with the controls (P< .01). Quality of life (P< .01) and symptoms (P< .001) also improved
significantly. These differences remained significant after one year follow-up. The control patients improved similarly
after their own spa treatment (day 450).
Conclusion: This study shows that spa therapy, associating balneotherapy and patient education, is able to improve
significantly the skin trophic changes of the CVD patients and their CVD related quality of life and symptoms. This effect
is of large magnitude and remains significant one year after the treatment course. ( J Vasc Surg 2009;49:163-70.)Patients with advanced chronic venous insufficiency (ie,
with CEAP C4 to C6 chronic venous disorders)1 suffer for
years from a painful and disabling condition,2 and they also
experience the limitations of the present possibilities of
medical care. Surgical or endovascular ablation of superfi-
cial refluxing veins is useful when there is an incompetence
of the superficial venous system,3 but few among the nu-
merous patients with deep vein damage are eligible for
surgery.4 The documented impact of venoactive drugs is
limited to an improvement of symptoms.5 Most patients
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Vascular Surgery.doi:10.1016/j.jvs.2008.07.075have to wear compression stockings and the poor compli-
ance of this treatment shows by itself that it is not the
perfect answer to their expectations.6 In this context, any
possibility of a treatment able to improve the function and
quality of life of the patients is welcome.
Although poorly evaluated in this condition, rehabili-
tation and physical therapy aiming at a restoration of calf
muscle pump function offer the potential for a useful
adjunctive treatment, and a randomized study by Padberg
et al showed promising results.7 Patient education is also
usually considered as useful in patients with such chronic
disabling conditions, in which the behavior of the patient
regarding lifestyle and compliance to treatments has to be
improved, and advanced chronic venous insufficiency obvi-
ously fulfills these two conditions.8
Spa treatment is a popular way to administer physical
therapy for chronic venous disorders (CVD) in France,
with more than 60,000 patients treated annually. Typically,
it is delivered as a three week treatment course in a spa
resort specialized in the treatment of CVD patients, and
combines the effects of active and intensive balneotherapy
using mineral waters with a patient education program
dedicated to CVD. It is partly reimbursed by the French
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although its efficacy has never been assessed in a scientific
way.9
The aim of this study was to evaluate, in a pragmatic
approach, the efficacy of spa treatment as it is performed in
the resort of La Léchère (balneotherapy with patient edu-
cation), in patients with advanced chronic venous insuffi-
ciency (ie, in patients with skin changes of the lower leg of
venous origin [CEAP clinical classes C4/C5]), in addition
to their usual treatments.
METHODS
Study design and organization. This study was orga-
nized as a single blind randomized controlled trial with two
parallel groups, the spa treatment being administered on
the top of the usual medical care. The tested hypothesis was
that patients with advanced chronic venous insufficiency
(CVD with CEAP C classes C4-C5) would have a long-
standing (remaining significant at month 12) improvement
of their signs, symptoms, and quality of life after a three
weeks spa treatment course in La Léchère as it is custom-
arily performed in this spa resort, compared with a random-
ized controlled group with no spa treatment.
Subjects. Inclusion criteria were primary or post-
thrombotic CVD (Ep or Es) with skin changes but no
active ulcer (C4 or C5), and the evidence of a venous
incompetence demonstrated by Ultrasound Duplex exam-
ination with at least a significant reflux (more than one
second duration in standing position) in the superficial,
deep, and/or perforator veins (Pr). Patients had to be at
least 18 years old, living in Grenoble area, and willing to
participate (written informed consent) in the study (ie, to
perform a three weeks course of spa treatment of in La
Léchère resort and a follow-up of 15 months duration
including a weekly self-administered questionnaire and a
medical examination every three months). Patients were
not included if they already had any prior spa treatment
course, if a surgical or endovascular treatment of the venous
disease was planned for the study time course or had been
performed less than six months prior to the inclusion visit.
Patients with contra-indication of spa treatment (life-
threatening disease, cardiac or renal failure, immunodefi-
ciency, psychiatric disorders, strong limitation of ambula-
tion) were also excluded, as well as those with edema of
non-venous origin (clinical lymphedema, cardiac failure,
hypoalbuminemia), symptomatic neurological diseases of
the lower limbs (neurogenic pain or abnormal neurological
examination of the lower limbs), or significant peripheral
arterial disease (ankle-brachial index [ABI] 0.90). The
study protocol was approved by the Grenoble Medical
Research Review Board (Comité de Protection des Per-
sonnes) on July 12, 2000.
Randomization. A centralized randomization was
performed after the inclusion visit, and its result kept hid-
den from the investigators. The treatment was then orga-
nized and carried out in La Léchère (100 km from
Grenoble), similarly to the customary procedure applied for
any patients undergoing the spa treatment for chronicvenous disorders, and the follow-up performed in
Grenoble University Hospital, by a blind investigator.
Intervention. The patients of the treatment group
underwent a three week spa treatment course in La Léchère
soon after randomization. The control group also had a spa
treatment, but after the comparison time course (ie, start-
ing soon after day 365 [Fig 1]).
The spa treatment course was performed according to
the rules of the French NHS and the study patient was
taken care of as any other CVD patient in the spa resort,
with his participation to the study being kept hidden. The
treatment regimen consisted of four balneotherapy sessions
per day, six days a week during three weeks, and two to
three educational workshops during the stay. The types of
balneotherapy sessions were chosen by the spa physician for
each patient according to his or her needs and capabilities
when he/she arrived at the spa resort. These choices were
subjected to adjustment on the occasion of the two fol-
low-up medical visits systematically performed during the
spa treatment course. Proposed care sessions were:
- A 15minute joint mobilization session in a deep (150 cm)
and warm (34 °C) pool under the supervision of a phys-
iotherapist (improvement of the ankle, but also knee and
hip joints’ mobility for a better ambulation and muscle-
pump functioning);
- A 15 minute walking session in a specially designed pool
with foot paths in a semi-deep (80 cm) and cool (28 °C)
water (training of the muscle pump function under water
compression);
- A 20minute whirlpool bath session with automatic air and
water massages cycles (aiming at relaxation and mobiliza-
tion of the superficial skin volume flow7);
- A 10minute under affusion massage session of the leg and
ankle skin areas by a physiotherapist (mobilization and
softening of the sclerotic subcutaneous tissues);
- A 10 minute bath session with customized underwater
strong massaging shower (same target).
All these spa sessions used the mineral waters of La
Léchère, emerging at 58 °C, but cooled down to 26 °C to
36 °C for therapeutic use. The mineralization of these
Fig 1. Pseudo cross-over design of the study: the comparison
addresses the first year (ie, the year after treatment for the treat-
ment group), vs. the year before treatment for the control group.waters is mainly made of calcium and magnesium sulfates.
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 1 Carpentier and Satger 165During the stay, the patient also participated in two to
three 90 minute educational workshops performed accord-
ing to a previously published method.8 These workshops
were interactive and involved small groups of patients (up
to eight persons), who shared knowledge, experience, and
skills through games and group activities under the super-
vision of a teaching nurse. The workshops were aiming at
increasing the understanding of venous pathophysiology
and the targets of venous treatments, but also the awareness
of the patient about the importance of his behavior regard-
ing exercise, weight and diet control, and an adequate use
of compression stockings. Through this improvement of
the patient’s knowledge, skills, and awareness, the work-
shops were thus aimed at increasing his motivation and
compliance with the treatments, and especially with the
compression stockings and the behavioral changes that
were needed in his or her everyday life. Due to organiza-
tional limitations, the patient was able to participate in two
to three among five workshops addressing the following
issues:
- What is the venous system? How does it work? What can
improve and what can hamper it?
- What kinds of dysfunctions do occur during chronic
venous disorders? How to control their consequences?
- Venous treatments: objectives and techniques.
- How to use and enjoy your compression therapy in
everyday life.
Concomitant treatments. During the whole study
time course, patients of both groups remained attended by
their usual physicians, who provided them with any care
they thought useful for their patients, according to the
regulations of the French National Health Service. No
standardized basal treatment or counseling was provided by
the investigators.
Main outcome measurements. The follow-up exam-
inations were performed at the Grenoble University Hos-
pital by the same investigator (BS) every three months
during the year of study course, and a final visit was per-
formed at month 15.
The primary outcome criterion was the severity of the
skin changes, evaluated as the intensity of the skin pigmen-
tation assessed by skin chromametry at the level of the
medial malleolar region. The chromameter is a small hand-
held device that is applied on the surface of the object to be
evaluated, in order to analyze the reflected light through
different kinds of filters after calibrated illumination with a
xenon flash. A calculator allows the online extraction of
three parameters that characterize the object’s color: pa-
rameters “a” for the green-red axis, “b” for the blue-yellow
axis, and “L” for the darkness of the object. In clinical
medicine, chromametry has been mainly used for the quan-
tification of the erythema (parameter “a”) as a marker of
vasodilatation or inflammation in vasomotor and cosmetic
studies;10,11 however, pigmentation (“brownish pigmen-
tary darkening of the skin in the ankle region”1), one of the
cardinal manifestations of skin disease in chronic venous
disorders, can also be assessed by chromametry.12 In aprevious study about chromametry in patients with CVD,
we found that the darkness parametermeasured at the ankle
was linearly related to the severity of the venous disease, as
classified according to the CEAP “C” classes; in the same
study, we showed that the repeatability, intra-, and inter-
observer reproducibility of the measurement were respec-
tively 15%, 18%, and 21% of the mean deviation, quite
adequate for clinical research studies.12 In the present
study, all measurements were carried out by the same
investigator. They were performed after a 10 minute rest,
the patient in supine position, with the Minolta CR-200
chromameter (Minolta France SA, Colombes, France)
placed orthogonally to the skin surface, in contact with the
medial malleola; the median value of three successive mea-
surements was recorded in order to decrease the variability
of the measurement. For a more simple expression of the
results, we derived the darkness parameter in a pigmenta-
tion index: PI  90 – L. These conditions were those
validated in our previous study.12 The chromametry mea-
surements were performed in both legs for each subject,
but only data regarding the most affected one were taken
into account in the statistical analysis.
Several additional variables were measured as secondary
outcome criteria:
- The “a” chromametry parameter (green-red axis), as an
index of skin erythema and dermatitis (erythema index),
was measured simultaneously with the pigmentation in-
dex.
- Quality of life was measured every three months by the
Chronic Venous Insufficiency Questionnaire 2 (CIVIQ2)
self-administered questionnaire, a disease specific quality
of life instrument dedicated to chronic venous disorders
and validated in this condition.13 In addition to the global
CIVIQ2 scale, its four dimensions (pain, physical, psycho-
logical, and social components) were separately analyzed.
- Self-evaluation of the intensity of leg symptoms was
performed each week by the patient him- or herself and
reported on a diary using two 10 cm height visual analog
scales (VAS). The symptoms’ intensity was rated sepa-
rately for each leg, from “no discomfort” at the bottom
end (measured 0.0), to “unbearable” at the top (mea-
sured 10.0), according to a method previously described
and discussed in detail.14 For the analysis, only the VAS of
the most affected leg was taken into account.
- The occurrence of leg ulcers was also recorded.
- Data regarding direct cost of medical and nursing cares
were recorded for subsequent medico-economic analysis,
but are not analyzed in this paper.
At each visit, any adverse events were recorded, as well
as any change in the treatment of the patient.
Data management and statistical analysis. Data
management was performed blindly, including a final blind
review regarding protocol deviations and missing data.
The main outcome analysis was conducted on an inten-
tion to treat approach. Only the data of the first study year
were used for the inter-groups comparisons, the primary
and main secondary outcome criteria being assessed at 12
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mandatory on a legal point of view as an end of study visit,
but was only analyzed as a supplementary evaluation of the
early effects of the spa treatment in the control group.
The statistical analyses were performed with SPSS soft-
ware (version 14.0 for Windows; SPSS, Inc., Chicago, Ill).
A variance analysis had been planned, with a P value below
.05 considered as significant. However, due to the non-
Gaussian distribution of some parameters, the Mann-
Whitney test was preferred. A Fisher exact test was per-
formed for categorical data. We also calculated Cohen’s
“d” effect size parameter as the / ratio (ie, the standard-
ized difference between the two groups); according to
Cohen, the effect size can be classified as “small, d  .2,”
“medium, d  .5,” or “large, d  .8”.15
As we expected a large effect size, we calculated the
number of patients required as 20 in each group (using a
bilateral test, with   .05,   .15, and /  1).
However, this hypothesis was based on poorly documented
potential outcomes (worsening by 15% of the pigmentation
in the control group vs 5% in the treated group, with a 10%
standard deviation) and we decided to include 60 patients
in order to accommodate potential problems of underesti-
mation of variability and possible drop outs.
RESULTS
Description of the subjects and interventions.
Sixty-three patients validating the inclusion criteria agreed
to participate, but four withdrew soon after randomization
and refused the follow-up. One late refusal was from a
woman from the treatment group because of personal
difficulties in the organization of her stay in the spa resort.
The three others came from subjects from the control
group: one for an unexplained personal reason; a second
one because of the onset of family problems; and the last
one because he expected an immediate spa treatment and
did not accept the result of the randomization. Therefore,
59 subjects were followed-up in the study (29 in the treated
group and 30 in the control group). No additional drop-
out occurred during the study time course, and, as no other
major protocol deviation was found, intent to treat and per
protocol analysis were identical. Less than 2% missing data
were found in the data base, mainly due to gaps in the
weekly VAS evaluations, and replaced for the purpose of the
analysis using a classical carry over procedure.
As shown in the Table, no statistically significant differ-
ence between the two groups was found at study onset
regarding age, sex, etiology, CEAP “C” class, and outcome
variables.
Regarding the balneotherapy sessions, all 29 patients of
the treated group had the under affusion massages and the
whirlpool sessions; twenty-six patients had the walking
pool session, and the three others who could not walk had
sessions of immerged pedaling in sitting position; nine
patients needed the mobilization pool sessions, and the
others had sessions of customized underwater massaging
showers. Four patients who did not want to participate in
the interactive workshops of therapeutic education wereproposed to attend a cycle of three educative conferences
on venous diseases and treatment.
Chromametry showed seasonal similar variations of the
skin pigmentation in both groups, which account for the
sinusoidal shape of the curves in Fig 2, A; this is explained
by the actinic pigmentation related to sun exposure. How-
ever, a significant difference in the pigmentation index was
found between the two groups, at months six (P .01) and
nine (P  .05). Furthermore, 12 months after the spa
treatment, and consequently adjusting for seasonal varia-
tions, the pigmentation index was reduced in the treatment
group, whereas it was increased in the controls, showing a
significant difference (P .01), with a size effect as high as
0.77.
Regarding the erythema index (Fig 2, B), the difference
was already found significant at month 3, and remained
significant during the whole study time course (P  .01),
with a size effect of 0.72 at month 12.
Quality of life, as expressed by the CIVIQ2 scale, also
improved significantly (P  .01) for the whole year of the
study course and remained significantly improved at month
12 with a size effect of 0.82 (Fig 3). The analysis of the four
components of this scale showed that all of them were
significantly improved, although the psychological dimen-
sion had a smaller magnitude than the three other ones
(Fig 4).
Leg symptoms, as assessed by the weekly self-evaluation
of VAS by the patient were also very much improved (P 
.001).The weekly evaluation allowed a more precise analy-
sis of the time course effect of the treatment. Fig 5 shows
that, as a mean value, the improvement started very early
during the spa treatment, became maximal during the first
Table. Description of patients groups at study onset (no
statistically significant difference)
Variables
Treated
(n  29)
Controls
(n  30)
Gender (F:M) 20:9 20:10
Age: mean (sd) 59.3 (10.6) 62.5 (10.9)
History of DVT 13 (45%) 17 (57%)
Venous Incompetence
(Ultrasound Duplex)
Superficial 27 (93%) 28 (93%)
Perforator 17 (59%) 18 (60%)
Deep 10 (35%) 14 (47%)
CEAP “C” Class
4a 21 15
4b 8 5
5 3 10
Early withdrawal 1* 3*
Other drop out 0 0
Pigmentation index: mean (sd) 4.4 (5.5) 5.9 (3.6)
Erythema index: mean (sd) 3.3 (2.1) 3.3 (1.4)
CIVIQ2 QoL scale: mean (sd) 52.8 (12.6) 52.2 (13.4)
Symptoms VAS: mean (sd) 4.1 (1.9) 3.9 (2.6)
CIVIQ2, Chronic Venous Insufficiency Questionnaire 2; DVT, deep vein
thrombosis; F, female;M,male;QoL, quality of life; VAS, visual analog scale.
*not included in the analysis.15 weeks after treatment, and decreased very slowly along
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week 52, and even with a large effect magnitude (size effect
0.84).
Incidence of leg ulcers. Only 6 ulcers occurred in this
small series of 59 patients during the study year; one in the
treated group and five in three patients from the control
group (Fisher exact test: P  ns).
The control group responded similarly to the treated
group after its own spa treatment (day 450), with the same
magnitude of improvement as in the treatment group re-
garding symptoms and quality of life (Figs 2-5). The three
months follow-up after treatment in this group did not
allow the detection of post-treatment changes in the chro-
mametry parameters.
Tolerance. Twenty-seven patients reported adverse
events in the treated group, and twenty-six in the control
Fig 2. Evolution of the chromametry parameters during the study.
(A) Pigmentation index (darkness parameter): Cohen’s D effect size
parameter at 12months 0.77. (B)Erythema index (redness param-
eter): Cohen’s D effect size parameter at 12 months  0.72. (*P 
.05; **P .01).group. All but one were unrelated to the spa treatment.Seven of these events required the hospitalization of the
patient; four in the treated group (newly diagnosed breast
cancer; scaphoid surgery; cholecystectomy; unexplained
thoracic pain) and three in the control group (prostate
surgery; giant cell arteritis; unexplained thoracic pain). The
only adverse event related to the spa therapy occurred in a
70-year-old woman from the control group, who experi-
enced a sensation of weakness and palpitations during a
bath session on the sixth day of her spa treatment (ie, after
the study comparison time course), with negative cardiac
explorations and no complications.
DISCUSSION
This study is the first randomized controlled trial eval-
uating the efficacy of spa therapy as an adjunct treatment to
the usual medical care in patients with severe CVD. A
significant improvement was shown on the CVD related
signs (pigmentation, erythema), symptoms (VAS), and
quality of life (CIVIQ2 scale). It is of large magnitude
(effect sizes .72 to .84) and long duration (at least one
year).
This trial was not carried out in a double-blind fashion.
This could have been possible for a comparison of the
effects of two different mineral waters or for the selection of
the best level of some technical parameters for a balneology
technique, but obviously, it was not possible for the evalu-
ation of the global effect of the spa treatment course, which
was our aim. However, we made all possible efforts to avoid
any evaluation bias:
- The treatment was administered 100 km from the fol-
low-up examination site, and the investigator was kept
blind about the treatment group of the patient as much
as possible.
- The primary outcome criterion was chosen as an operator-
independent one, and the data management including
the statistical analysis was performed blindly until the
Fig 3. Evolution of CIVIQ2 quality of life instrument during the
study. Cohen’s D effect size parameter at 12 months  0.82
(**P  .01).final between groups comparison.
CIV
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qualify the quality of life as the primary outcome crite-
rion. This would have been relevant, as quality of life is
closely related to the therapeutic objectives in such
patients with a non-life threatening but painful and
disabling condition. However, the possibility that the
judgment of the patient might be influenced by the
Fig 4. Evolution of the four dimensions of the
Fig 5. Evolution of the pain scale (Visual Analogic Scale) during
the study. Cohen’s D effect size parameter at 12 months  0.84.
(P  .001 from week 4 to week 52).subjective satisfaction to be actively treated in a pleasantenvironment could not be ruled out when preparing
the study (indeed, the analysis showed afterward that
CIVIQ2 quality of life auto-questionnaire was more
improved in the physical dimensions than in the psy-
chological one). Therefore, we preferred a measure-
ment independent from patient judgment, such as the
skin pigmentation index, as the primary outcome
criterion.
Hence, it is a strength of this study to rely on a physical
sign as the primary endpoint, and chromametry is confirm-
ing here its ability to be used in clinical research studies, as
a reliable and sensitive to change quantitative marker of the
severity of skin changes in venous disease. By itself, pigmen-
tation remains a surrogate criterion for skin disease severity
in patients with CVD; however, the magnitude of the effect
shown and its consistency with an associated substantial
improvement of symptoms and quality of life are impressive
and convincing.
The unusual design of the study (Fig 1), with a spa
treatment performed at the end of the study time course in
the control group, was adapted from previous studies by
the Nancy group regarding the efficacy of spa therapy in
severe low back pain.16 We chose this design in order to
avoid dropouts in the control group, and also to allow the
detection of a potential negative placebo effect in this
group: subjects of the control group could have felt frus-
IQ2 instrument during the study. (*P  .05).trated not to have the immediate spa treatment, and this
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their quality of life and symptoms. In this study, such a
significant influence of negative feelings in the control
group can reasonably be ruled out, since no significant
worsening of the VAS andCIVIQ2was shown immediately
after randomization nor during the last weeks of the com-
parison period (ie, the weeks prior to their spa treatment) in
the control group, and also because the magnitude of the
effect of the spa treatment in this group, as shown in the 12
to 15month follow-up of the study, was similar to what had
been previously seen in the treatment group. In any case,
our primary endpoint, the pigmentation index, could not
have been influenced by such psychological factors.
The treatment tested in this work was the spa therapy as
a whole, as it is experienced by 7,000 patients in La Léchère
each year, with a three week stay far enough from home to
withdraw the patients from his usual environment, an in-
tensive balneotherapy of 72 sessions using the local mineral
water under the supervision of a physician specialized in spa
medicine, and the patient education program specifically
developed for these patients. It was important that the
validation was made in this way because these are the
conditions of the reimbursement of the spa treatment by
the National Health Services in France. Therefore, the
positive results found include the effects of every compo-
nent and their potential synergy. This study does not allow
us to differentiate between the effects of each component,
including the possible effects of the mineral water17 and the
impact of the psycho-sociological influence of a health-
centered stay of three weeks 100 km from home. However,
the association of intensive active balneotherapy and pa-
tient education is the central core of the treatment, and we
feel that it accounts for the main part of effects on physical
signs of such large magnitude and long duration.
Few data can be found in the literature regarding the
effects of balneotherapy in patients with chronic venous
disorders. Ernst and Saradeth18 showed in a randomized
study that the Kneipp technique (alternate warm and cold
water showers) was able to improve venous function as
evaluated by photoplethysmography, and edema measured
by volumetry in the short term. A similar study by Mancini
et al,19 performed in a spa resort with a follow-up of six
months in a small number of patients, also showed an
improvement of the venous function. Supervised exercise
without balneotherapy was also shown to improve calf
muscle pump function in the short term20,21 and after a six
month training.7 Although this was not directly measured
in our study, a remarkable increase in the ability to walk,
both qualitatively and quantitatively, is usually observed
during such an intensive spa treatment, and the level of
improvement could be as high as to allow changes in
behavior able to have strong and long lasting effects.
On the other hand, advanced chronic venous insuffi-
ciency fulfills the criteria for a beneficial effect of therapeutic
education, as it is a chronic, disabling condition, requiring
from the patients changes in their lifestyle (exercising, diet
control) and the use of treatments such as compression
stockings, requiring some skills and a high motivation inorder to achieve a good therapeutic compliance. However,
this approach has been scarcely developed up to now,
except in the spa resorts. The program developed in La
Léchère showed a positive impact on patient knowledge
and understanding of the venous disease on the short term
in an observational study,8 and a positive influence on the
patients’ compliance to compression stockings in an other
mid-term (six month) survey [unpublished data]. How-
ever, no controlled evaluation of this educational program
has been performed up to now.
We hypothesize that active balneotherapy and thera-
peutic education have synergistic effects and that their
combination makes a very powerful tool able to obtain
long-lasting changes in the behavior of the patient regard-
ing physical activity, diet control, and compliance to com-
pression therapy: During the active and intensive bal-
neotherapy (72 sessions in three weeks), the patients
experience the strong influence of physical factors on their
body, thus demonstrating practically what they understand
theoretically during the educational workshops. And dur-
ing the workshops, they learn how to adapt some of the
behaviors and exercises they have observed as beneficial
during the balneotherapy sessions to their everyday life. For
example, the edema reduction they observe after the bath
helps them to realize how important is the beneficial effect
of the external pressure produced by the compression
stockings; they also understand the link between the im-
provement in their walking technique, the improvement of
ankle joint mobility they experience during the stay, and
the improvement of their symptoms. These personal expe-
riences give the patients a high motivation for the behav-
ioral changes they need to implement in their everyday life
when returning home. In other words, the magnitude and
more over the duration of the effects shown in this study
cannot be explained unless deep changes were obtained in
the behavior of the patient, which, unfortunately, were not
directly evaluated in this study; we believe that these effects
result from the combination of both active balneotherapy
and therapeutic education.
The results demonstrated here strictly apply only to the
spa treatment in the very same conditions as it is performed
in La Léchère. However, they strongly support the use of
intensive active balneotherapy associated with therapeutic
education as a powerful complement of the usual medical
care (mainly compression therapy) applied in patients with
advanced venous insufficiency, at least for those patients for
whom no definite benefit can be expected from the surgical
or endovascular treatment of superficial venous incompe-
tence. To a larger extent, they also confirm the interest of
physical therapy in this condition, as already shown in
previous studies.7,20,21 The magnitude and duration of the
results obtained in a disabling, widespread, and difficult to
treat condition such as severe chronic venous disorders
speaks in favor of further evaluations of this therapeutic
regimen, looking for the most important components for
an efficient treatment course, and evaluating to what extent
they can be transposed to other medical settings.
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January 2009170 Carpentier and SatgerIn fact, as its tolerance is usually very good in the
absence of the above mentioned contraindications,22 we
think that this spa treatment course could be proposed to
all patients with advanced chronic venous insufficiency who
can invest three full weeks in an intensive health stay,
whenever a satisfactory hemodynamic restoration of the
venous function is out of range, especially in the post-
thrombotic syndrome.
CONCLUSION
This study shows that spa therapy, as performed in La
Léchère, with a combination of active balneotherapy and
patient education, is able to improve significantly the skin
trophic changes and the CVD related quality of life and
symptoms in the severe CVD patients when used as an
adjunct to the usual medical care. The effect is of large
magnitude and remains significant one year after the spa
treatment, justifying its use in patients with advanced
chronic venous insufficiency and no possible surgical or
endovascular correction of the venous function. The ex-
portability of such results to other medical settings remains
to be investigated.
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